The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer

scientific article published on 8 April 2013

The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/FEBS.12236
P698PubMed publication ID23480797

P50authorJaroslaw SzczyrbaQ43852131
Helge TaubertQ56519855
Friedrich GrässerQ88368821
Arndt HartmannQ89782316
Roopika MenonQ90316695
P2093author name stringBernd Wullich
Robert Stoehr
Sven Wach
Elke Nolte
Martin Hart
Wolf Wieland
P2860cites workMicroRNA145 targets BNIP3 and suppresses prostate cancer progressionQ24304475
Real-time quantification of microRNAs by stem-loop RT-PCRQ24535510
The functional significance of microRNA-145 in prostate cancerQ24606503
Putative tumor suppressor miR‐145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 geneQ24632934
p53 represses c-Myc through induction of the tumor suppressor miR-145Q24644779
MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1Q24647663
miRecords: an integrated resource for microRNA-target interactionsQ24655642
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.Q27824849
Oncomirs - microRNAs with a role in cancerQ27860773
Analyzing real-time PCR data by the comparative C(T) methodQ28131831
Interaction of two multifunctional proteins. Heterogeneous nuclear ribonucleoprotein K and Y-box-binding proteinQ28144366
Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMTQ28744173
Understanding alternative splicing: towards a cellular codeQ29615085
A combined computational-experimental approach predicts human microRNA targetsQ29619021
Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expressionQ31081505
Antibody-based detection of ERG rearrangement-positive prostate cancerQ34009867
Isolation of a human prostate carcinoma cell line (DU 145)Q34255312
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancerQ34803786
TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers.Q35165354
ETS transcription factors and their emerging roles in human cancerQ36280928
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumorQ36710981
miRNAs get an early start on translational silencingQ36965104
Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcriptsQ37003441
Alternative splicing and biological heterogeneity in prostate cancerQ37573399
Widespread deregulation of microRNA expression in human prostate cancer.Q38297946
Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.Q39540283
Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146aQ40001339
MicroRNA expression profiling in prostate cancerQ40110318
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancerQ40236533
Suitable reference genes for relative quantification of miRNA expression in prostate cancerQ41475887
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasQ41854285
Gene networks and microRNAs implicated in aggressive prostate cancerQ42128568
The microRNA profile of prostate carcinoma obtained by deep sequencingQ43852104
The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrumQ45285560
Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinomaQ46495042
ERG is a megakaryocytic oncogene.Q47677556
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectmicroRNAQ310899
prostate cancerQ181257
P304page(s)2105-2116
P577publication date2013-04-08
P1433published inFEBS JournalQ1388041
P1476titleThe proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer
P478volume280

Reverse relations

cites work (P2860)
Q47246071A Peptide Nucleic Acid against MicroRNA miR-145-5p Enhances the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells
Q37597723Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes.
Q61809489Circular RNA: a novel biomarker and therapeutic target for human cancers
Q92667802Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays
Q38843392Deciphering the function of non-coding RNAs in prostate cancer.
Q96765767Decreased miR-200b-3p in cancer cells leads to angiogenesis in HCC by enhancing endothelial ERG expression
Q41967527Demethylation of the MIR145 promoter suppresses migration and invasion in breast cancer
Q37295759Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer
Q92072526Ensemble of decision tree reveals potential miRNA-disease associations
Q35608000Expression of ERG protein in prostate cancer: variability and biological correlates
Q47224473GIMDA: Graphlet interaction-based MiRNA-disease association prediction.
Q40769779Identification of miR-34a-target interactions by a combined network based and experimental approach
Q26783563Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis
Q64121783Inferring microRNA-disease association by hybrid recommendation algorithm and unbalanced bi-random walk on heterogeneous network
Q100945947Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma
Q35961920Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1.
Q33591474MCMDA: Matrix completion for MiRNA-disease association prediction
Q35225191MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma
Q39051553MiRNA regulation of TRAIL expression exerts selective cytotoxicity to prostate carcinoma cells
Q34571491MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways
Q38667234Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications
Q26782530Prognostic role of microRNA-145 in prostate cancer: A systems review and meta-analysis
Q38958582Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells
Q26747155Regulation of endothelial homeostasis, vascular development and angiogenesis by the transcription factor ERG
Q39067486TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c
Q89998761The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells
Q38444138The oncogene ERG: a key factor in prostate cancer
Q38859577The roles of microRNAs in the progression of castration-resistant prostate cancer
Q26995383Tumor suppressor microRNAs: a novel non-coding alliance against cancer
Q36583369WBSMDA: Within and Between Score for MiRNA-Disease Association prediction
Q45942966[Minutes of the meeting of the Working Group on Uropathology].
Q38921152miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer.
Q39120421miR-145 suppresses osteogenic differentiation by targeting Sp7.
Q91933172miR-34a as hub of T cell regulation networks
Q38791639microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients
Q53767542microRNAs and Prostate Cancer.
Q34978603μHEM for identification of differentially expressed miRNAs using hypercuboid equivalence partition matrix.

Search more.